Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA proposes asbestos-testing standards for talc products
FDA wants new testing to detect asbestos in products with talc
The proposed rule is required under a law passed by Congress last year, and is intended to ensure the safety of makeup and baby powder.
US FDA proposes standardized testing to detect asbestos in talc products
The U.S. Food and Drug Administration is proposing that cosmetic products containing talc should be tested using standardized methods to detect asbestos, a potential contaminant, according to documents posted on the federal register on Thursday.
FDA proposes rule to target asbestos in talc cosmetic products
The U.S. Food and Drug Administration (FDA) has proposed a new rule to require standardized testing of talc-containing cosmetics for asbestos, a known carcinogen linked to serious illnesses.
2d
What's Next For Johnson & Johnson's Talcum Powder Litigation?
Potential legal and legislative battles are sure to dominate Johnson & Johnson’s talcum powder litigation in 2025.
devdiscourse
1d
Health News Highlights: Talc Testing and Bird Flu Mutations
Recent health developments include the FDA's proposal for standardized testing of talc products for asbestos detection and ...
1d
on MSN
Man sues Johnson & Johnson for $25m claiming talcum powder killed his wife
Man sues Johnson & Johnson for $25m claiming talcum powder killed his wife - The lawsuit, filed in Maine, claims Cynthia ...
UPI on MSN
1d
TNF inhibitors might help prevent serious complications in kids with Crohn's Disease
This frequently involves fitting the child with a colostomy bag. Related FDA proposes rule to target asbestos in
talc
...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
FDA
asbestos
Food and Drug Administration
Johnson & Johnson
Reuters
Feedback